Positive Airway Pressure Devices market to Eyewitness Huge Marginal Growth by 2027
The global positive
airway pressure devices market
size is anticipated to reach USD 2.7
billion by 2025, expanding at a CAGR
of 7.0%, according to a new report by Grand View Research, Inc. An increase
in the patient pool suffering from Obstructive Sleep Apnea (OSA) is one of the
key factors anticipated to drive the market growth. Furthermore, an increase in
the compliance rate of positive airways pressure (PAP) machines due to growing
awareness for sleep apnea and its associated disorders is likely to drive
growth over the forecast period. However, the availability of alternative
treatment options such as nasal surgery, uvulopalatopharyngoplasty (UPPP), and
mandibular maxillomandibular advancement surgery and the on-going clinical
trials for the development of sleep apnea medications are some of the major
challenges to the market growth.
In 2018, the CPAP device dominated the
market, with a revenue of USD 1.3 billion. The penetration of CPAP is
increasing owing to improved patient outcomes and favorable reimbursement
policies across various countries. Moreover, the launch of portable
travel-friendly CPAP machines has also influenced the growth of this segment.
On the other hand, the BiPAP device is expected to exhibit the fastest growth
rate over the forecast period, owing to its higher efficiency compared to other
PAP devices.
North America dominated the market in
2018, with a revenue share of 47.4%, owing to the presence of a large patient
pool in the region. Furthermore, the presence of major players and increasing
awareness related to OSA and its consequences are some of the secondary factors
driving the growth in this region. Moreover, the region is anticipated to grow
at the fastest rate over the forecast period, due to high healthcare
expenditure and availability of medical insurance coverage in the region.
According to a study conducted by the
American Academy of Sleep Medicine (AASM) in 2016, the annual economic burden
caused due to undiagnosed sleep apnea among U.S. adults was approximately USD
149.6 billion. Whereas, treated sleep apnea would result in an annual economic
savings of over USD 100 billion in the country. Due to this, the government
institutions across various regions have started focusing on increasing the
overall treatment rate by creating awareness among citizens on obstructive
sleep apnea and its treatment, thus, boosting the demand for positive airways
pressure (PAP) machines globally.
Have a Query? Ask
Our Expert:
https://www.grandviewresearch.com/inquiry/6864/ibb
The market is oligopolistic and is
consolidated with limited number of companies operating in this space. Some of
the players operating in this market include Koninklijke Philips N.V. (Philips
Respironics); Curative Medical; ResMed; Fisher and Paykel Healthcare Limited;
Drive DeVilbiss Healthcare Inc.; and Somnetics International, Inc. These
companies are focused on new product development, strategic acquisitions, and
developing partnerships to gain higher market share. Moreover, strong
geographic presence in multiple countries, a wide product portfolio, and a
large number of distributors has helped the key players to strengthen their
market presence.
Further key
findings from the report suggest:
- The global PAP Devices market is
anticipated to be USD 2.7 billion by 2025, owing to the high prevalence of
OSA
- CPAP devices accounted for a major share
in 2018 with a revenue of USD 1.3 billion, owing to the increasing
awareness about sleep apnea related treatments among patients
- North America dominated the market in
2018, owing to the availability of favorable reimbursement policies for
PAP devices in the region
- Some of the key players are Koninklijke
Philips N.V. (Philips Respironics); Curative Medical; ResMed; Fisher and
Paykel Healthcare Limited; and Drive DeVilbiss Healthcare, Inc.
Grand View Research has segmented the
global PAP devices market based on product type:
PAP Devices
Product Type Outlook (Revenue, USD Million, 2014 - 2025)
- CPAP
- APAP
- BiPAP
About Grand View
Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More
Information:www.grandviewresearch.com
Comments
Post a Comment